These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin. Cornish JL; van den Buuse M Brain Res; 1995 Dec; 701(1-2):28-38. PubMed ID: 8925292 [TBL] [Abstract][Full Text] [Related]
24. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5. Berglund MM; Saar K; Lundell I; Langel U; Larhammar D Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204 [TBL] [Abstract][Full Text] [Related]
25. Galanin-like immunoreactivity in sympathetic and parasympathetic neurons of the toad Bufo marinus. Morris JL; Gibbins IL; Osborne PB Neurosci Lett; 1989 Jul; 102(2-3):142-8. PubMed ID: 2478927 [TBL] [Abstract][Full Text] [Related]
27. Vasoconstrictor effects of galanin and distribution of galanin containing fibres in three species of elasmobranch fish. Preston E; McManus CD; Jonsson AC; Courtice GP Regul Pept; 1995 Aug; 58(3):123-34. PubMed ID: 8577924 [TBL] [Abstract][Full Text] [Related]
28. The combination of neurokinin-1 and galanin receptor antagonists ameliorates caerulein-induced acute pancreatitis in mice. Barreto SG; Carati CJ; Schloithe AC; Toouli J; Saccone GT Peptides; 2010 Feb; 31(2):315-21. PubMed ID: 19944731 [TBL] [Abstract][Full Text] [Related]
29. An endocrinological update in toads: disparity between the cardiovascular effects of two angiotensin II analogs. Slivkoff MD; Warburton SJ Gen Comp Endocrinol; 2003 Jun; 132(1):125-32. PubMed ID: 12765652 [TBL] [Abstract][Full Text] [Related]
30. Galanin receptor antagonist m35 but not m40 or c7 ameliorates cerulein-induced acute pancreatitis in mice. Bhandari M; Kawamoto M; Thomas AC; Barreto SG; Schloithe AC; Carati CJ; Toouli J; Saccone GT Pancreatology; 2010; 10(6):682-8. PubMed ID: 21242707 [TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical study of the innervation of the large intestine of the toad (Bufo marinus). Murphy S; Campbell G Cell Tissue Res; 1993 Oct; 274(1):115-25. PubMed ID: 7694798 [TBL] [Abstract][Full Text] [Related]
32. Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse. Smith-White MA; Iismaa TP; Potter EK Br J Pharmacol; 2003 Sep; 140(1):170-8. PubMed ID: 12967946 [TBL] [Abstract][Full Text] [Related]
33. Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Horvath TL; Naftolin F; Leranth C; Sahu A; Kalra SP Endocrinology; 1996 Jul; 137(7):3069-78. PubMed ID: 8770933 [TBL] [Abstract][Full Text] [Related]
34. The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1-15). Narváez JA; Díaz-Cabiale Z; Hedlund PB; Aguirre JA; Coveñas R; González-Barón S; Fuxe K Eur J Pharmacol; 2000 Jul; 399(2-3):197-203. PubMed ID: 10884520 [TBL] [Abstract][Full Text] [Related]
35. Galanin receptors in human basal forebrain differ from receptors in the hypothalamus: characterization using [125I]galanin (porcine) and [125I]galantide. Deecher DC; Odusan OO; Mufson EJ J Pharmacol Exp Ther; 1995 Nov; 275(2):720-7. PubMed ID: 7473159 [TBL] [Abstract][Full Text] [Related]
36. Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents. Aubert JF; Waeber B; Rossier B; Geering K; Nussberger J; Brunner HR J Pharmacol Exp Ther; 1988 Sep; 246(3):1088-92. PubMed ID: 2843627 [TBL] [Abstract][Full Text] [Related]
37. The Galanin N-terminal fragment (1-15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype. Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA Regul Pept; 2010 Aug; 163(1-3):130-6. PubMed ID: 20451563 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Wynick D; Smith DM; Ghatei M; Akinsanya K; Bhogal R; Purkiss P; Byfield P; Yanaihara N; Bloom SR Proc Natl Acad Sci U S A; 1993 May; 90(9):4231-5. PubMed ID: 7683428 [TBL] [Abstract][Full Text] [Related]
39. Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw. Xu XJ; Hao JX; Wiesenfeld-Hallin Z; Håkanson R; Folkers K; Hökfelt T Neuroscience; 1991; 42(3):731-7. PubMed ID: 1720225 [TBL] [Abstract][Full Text] [Related]
40. Galanin antagonist effects on cardiac vagal inhibitory actions of sympathetic stimulation in anaesthetized cats and dogs. Ulman LG; Moriarty M; Potter EK; McCloskey DI J Physiol; 1993 May; 464():491-9. PubMed ID: 7693918 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]